GovWire

Decision: Regulatory approval of COVID-19 Vaccine AstraZeneca

Medicines Healthcare Products Regulatory Agency

April 7
15:23 2021

Details

Information about the COVID-19 Vaccine AstraZeneca, approved by the MHRA on 30 December 2020.

The Information for healthcare professionals document is a description of a medicinal products properties and the conditions attached to its use. It explains how to use and prescribe a medicine. It is used by healthcare professionals, such as doctors, nurses and pharmacists.

The Information for UK recipients document provides information for patients on using the medicine safely. This is based on the Information for healthcare professionals of the product.

The public assessment report is a scientific report, written by the MHRA. It explains how this product was assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use this product.

Find out more about the approval from our press release.

For further information on prioritising the first COVID-19 vaccine dose see the statement from the Joint Committee on Vaccination and Immunisation (JCVI).

Ingredients

The MHRA can confirm that the COVID-19 Vaccine AstraZeneca does not contain any components of animal origin.

A full list of ingredients for the qualitative and quantitative composition of the vaccine can be found at point 2 in the

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: